Abvc BiopharmaABVC
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 14 institutions reported holding Abvc Biopharma Inc. (ABVC) in their 13F filings, up 5 from Q2 2025. 6 opened new positions and 1 sold out. The largest holders were Vanguard Group Inc. ($813K), Geode Capital Management, LLC ($571K) and Renaissance Technologies ($336K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Abvc Biopharma Inc.
- CUSIP
- 00091F304
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $288K |
| Exits | 1 | $1K |
All 13F filers, Q2 2025 → Q3 2025: 458,583 shares bought and 40,630 shares sold, net +417,953 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Vanguard Group Inc. | 0.00% | Add +139.8% | 267,450 | $813K |
| Geode Capital Management, LLC | 0.00% | Add +70.0% | 187,812 | $571K |
| Renaissance Technologies | 0.00% | Add +164.9% | 110,500 | $336K |
| State Street Corp. | 0.00% | Add +464.3% | 72,800 | $221K |
| BlackRock, Inc. | 0.00% | New | 56,442 | $172K |
| Northern Trust Corp. | 0.00% | Reduce -33.2% | 24,821 | $75K |
| XTX Topco Ltd | 0.00% | Reduce -52.9% | 24,801 | $75K |
| Millennium Management | 0.00% | New | 19,603 | $60K |
| Citadel Advisors | 0.00% | New | 15,664 | $48K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +508.8% | 2,155 | $7K |
| UBS Group AG | 0.00% | New | 1,849 | $6K |
| Simplex Trading, LLC | 0.00% | New | 1,108 | $3K |
| Bank of America Corp. | 0.00% | Add +31.6% | 175 | $532 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 150 | $456 |
"% of holder's portfolio" is ABVC's weight in each manager's 13F, not the share of Abvc Biopharma Inc. the manager owns.